Events & presentations

Internal link Conference call additional sepofarsen analyses and company strategy update

ProQR shared additional analyses from the Phase 2/3 Illuminate trial of sepofarsen for LCA10 and provided an update on the company strategy. Management to host a conference call today at 8:00am EDT (14:00 CET).

• Add Conference call additional sepofarsen analyses and company strategy update to calender

Internal link Conference call top-line results Phase 2/3 Illuminate trial

ProQR to host a conference call to discuss the top-line results of the Phase 2/3 Illuminate clinical trial of investigational RNA therapy sepofarsen in CEP20-mediated LCA10.

• Add Conference call top-line results Phase 2/3 Illuminate trial to calender

Internal link ProQR Analyst Event

During this webcast ProQR leadership will highlight key advancements from its clinical-stage pipeline and Axiomer® RNA editing platform.

• Add ProQR Analyst Event to calender

Internal link American Academy of Ophthalmology (AAO) Annual Meeting 2021

ProQR to participate in the American Academy of Ophthalmology (AAO) Annual Meeting 2021

• Add American Academy of Ophthalmology (AAO) Annual Meeting 2021 to calender

Internal link EFF Fall Virtual Summit 2021 - The Science of RNA Therapies

The Eye on the Future Forum (EFF) is a platform hosted by ProQR on innovative clinical development approaches for genetic eye diseases. This Fall Summit will explore the Science of RNA Therapies.

• Add EFF Fall Virtual Summit 2021 - The Science of RNA Therapies to calender

• Healthcare professionals
• Patient